Clinical and Experimental Pharmacology and Physiology · 2016 · 28 citations · 30 references
Life SciencesCell BiologyNeuroscienceApoptosisCell JunctionsCellular NeuroscienceBlood-brain Barrier BiologyBlood-brain Barrier DysfunctionEndothelial DysfunctionHypoxic-ischemic Brain InjuryMembrane InjuryVascular PermeabilityBlood-brain Barrier PermeabilityCell Viability AssaysCerebral Endothelial Cell BiologyCerebral Oxygen Glucose DeprivationIschemia-induced Barrier DisruptionMonolayersProtein Expression LevelsTight Junction Adhesion Proteins
Studies have utilised immortalised mouse cerebral endothelial cells (bEnd.3) exposed to oxygen glucose deprivation (OGD) to study blood-brain barrier (BBB) disruption after ischaemia. However, there is a paucity of literature describing the duration of OGD (and reoxygenation [RO]) required to best simulate BBB disruption in vivo. In this study we assessed BBB disruption in bEnd.3 cells after exposure to a range of OGD periods, and also after OGD + RO. Exposure of bEnd.3 monolayers to 4, 6, 16, or 24 hours of OGD resulted in a significant increase in permeability. The hyperpermeability after 16 or 24 hours was associated with decreased expression of tight junction proteins (occludin and claudin-5). Furthermore, there was a decrease in cell viability and increased expression of the pro-apoptotic protein, cleaved caspase-3. Exposure of bEnd.3 monolayers to 1 hour OGD+ 23 hours RO exacerbated hyperpermeability relative to 1 hour OGD, which was associated with decreased expression levels of occludin and ZO-1, but no change in cell viability or caspase-3. 4 hours OGD + 23 hours RO exacerbated hyperpermeability, decreased expression levels of tight junction proteins, decreased cell viability, and increased caspase-3 expression. Thus, bEnd.3 cells exhibit hyperpermeability, a loss of tight junction proteins, and undergo cell death, after exposure to prolonged periods of OGD. Moreover, they exhibit exacerbated hyperpermeability, a loss of tight junction proteins, and increased expression of caspase-3 after OGD + RO. These findings will facilitate the use of this cell line in studies of BBB disruption and for the testing of therapeutics.
30
Jie Liu, Xinchun Jin, Ke J. Liu et al. · Journal of Neuroscience · 2012 · 423 citations · Full text
Marcellino Monda, Ilaria Scognamiglio, Angela Lombardi et al. · Oxidative Medicine and Cellular Longevity · 2014 · 412 citations · Full text